Vancomycin use in pediatric hematology-oncology patients

Infection Control and Hospital Epidemiology

Volumn 21, Issue 1, 2000, Pages 48-50

  Hopkins, Heidi A ^a   Sinkowitz Cochran, Ronda L ^a,c   Rudin, Benjamin A ^a   Keyserling, Harry L ^b   Jarvis, William R ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b EMORY UNIVERSITY   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CANCER CENTER; CHILD; CROSS-SECTIONAL STUDY; DRUG USE; FEMALE; HUMAN; IMMUNE DEFICIENCY; INFANT; INFECTION CONTROL; MALE; PRACTICE GUIDELINE; PRESCHOOL CHILD; STANDARD; UNITED STATES;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION REVIEW; FEMALE; GEORGIA; GUIDELINE ADHERENCE; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; INFECTION CONTROL; MALE; ONCOLOGY SERVICE, HOSPITAL; PRACTICE GUIDELINES; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 0033628363     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/501698     Document Type: Article

References (10)

1. Shay DK, Maloney SA, Montecalvo M, Banerjee S, Wormser GP, Arduino MJ, et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis 1995;172:993-1000.
2. Rubin LG, Tucci V, Cercenado E, Eliopoulos G, Isenberg HD. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol 1992;13:700-705.
3. Shay DK, Goldmann DA, Jarvis WR. Reducing the spread of antimicrobial-resistant organisms: control of vancomycin-resistant enterococci. Pediatr Clin North Am 1995;42:703-716.
4. Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995;16:105-113.
5. Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, et al. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med 1999;340:493-501.
6. Sinkowitz RL, Keyserling H, Walker TJ, Holland J, Jarvis WR. Epidemiology of vancomycin usage at a children's hospital, 1993 through 1995. Pediatr Infect Dis J 1997;16:485-489.
7. Ena J, Dick RW, Jones RN, Wenzel RP. The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study. JAMA 1993;269:598-602.
8. Evans ME, Kortas KJ. Vancomycin use in a university medical center: comparison with Hospital Infection Control Practices Advisory Committee guidelines. Infect Control Hasp Epidemiol 1996;17:356-359.
9. Johnson SV, Hoey LL, Vance-Bryan K. Inappropriate vancomycin prescribing based on criteria from the Centers for Disease Control and Prevention. Pharmacotherapy 1995;15:579-585.
10. Watanakunakorn C. Prescribing pattern of vancomycin in a community teaching hospital with low prevalence of vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 1997;18:767-769.